Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products by unknown
Brief Definitive Report 
MURINE  TISSUE  AMYLOID  PROTEIN  AA 
NH2-Terminal Sequence Identity with Only One of Two Serum 
Amyloid Protein (ApoSAA) Gene Products 
BY JEFFREY  S.  HOFFMAN,  **  LOWELL  H.  ERICSSON,*  NILS  ERIKSEN, * 
KENNETH  A.  WALSH,*  AND EARL  P.  BENDITT* 
From the Departments of *Biochemistry and *Pathology, University of Washington, 
Seattle, Washington 98195 
In  amyloidosis associated with  chronic  inflammatory disease processes,  the 
characteristic extracellular protein fibrils that form deposits in various tissues are 
largely composed of an 8.5-kd polypeptide called protein AA (1, 2). Amino acid 
sequence analysis reveals that protein AA is homologous to the NH2-terminal 
portion of a  12-kd high density lipoprotein (HDL) ~ apoprotein, apoSAA (2-5). 
ApoSAA is  normally a  trace plasma constituent but  is  elevated many fold in 
response to a  variety of disease states and pathologic conditions (6,  7).  Since 
chronically elevated plasma apoSAA levels are predisposing to protein AA-type 
amyloidosis,  it  is  currently believed  that  in  amyloidosis a  precursor-product 
relationship exists in which elevated apoSAA levels lead to the accumulation of 
the partial breakdown product, protein AA, found in amyioid fibril deposits. 
Recent studies of apoSAA structure have revealed that in several mammalian 
species more than one form of apoSAA exists.  In humans, two major (8)  and 
four minor (9) apoSAA isotypes have been identified. Similarly, in  the rabbit 
(10), monkey (1 1), mink (12), and mouse (12, 13) two electrophoretically distinct 
apoSAA isotypes have been described. The two murine apoSAA isotypes, apo- 
SAA~ (12.6 kd, pI =  6.35) and apoSAA~ (1 1.8 kd, pI  =  6.20), are present in 
nearly equal amounts and constitute as much as 20%  of the total mouse HDL 
protein content during acute inflammation (13). With regard to amyloidosis, a 
question of interest is whether one or both apoSAA isotypes contribute to the 
formation of amyloid protein AA deposits.  To address this question, we have 
purified the two major murine apoSAA isotypes, characterized them by NH2- 
terminal amino acid analysis, and compared the sequences obtained with that of 
murine amyloid protein  AA.  Our  results indicate that the two major murine 
apoSAA isotypes are separate gene products and that amyioid protein AA has 
NH2-terminal identity with only one of these, namely apoSAA2. 
Materials and Methods 
Sources and Purification  of ApoSAA  and Protein AA.  ApoSAA was obtained from the 
pooled serum of mice  20 h  after intraperitoneal administration  of 50 #g of bacterial 
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lipopolysaccharide (Salmo~ella  t~,phi lipopolysaccharide W,  Difco  Laboratories,  Detroit, 
MI), as described previously (13). BALB/c mice were obtained from a stock maintained 
in the Department of Microbiology and Immunology at the University of Washington. 
C57BL/KsJ and CBA/J mice were purchased from The Jackson Laboratory (Bar Harbor, 
ME). 
HDL (1.063 <  d <  1.21 g/ml) was prepared by sequential ultracentrifugation and the 
delipidated apoproteins were separated by analytical isoelectric  focusing using pH  3.5- 
10.0 ampholytes (400  /lg protein applied per gel), as described previously (13).  Bands 
containing apoSAA~ and apoSAA2 were located by reference to opaque areas of compan- 
ion gels, fixed in a solution of 14.7% trichloroacetic acid and 4% sulfosalicylic acid. The 
apoproteins  were  eluted  from excised and  homogenized gel  slices  by  two  successive 
extractions in ~ I 0 vol of 8 M urea/formic acid, pH 3.0, with overnight mixing by vortex 
at room temperature.  The extracts were then dialyzed in Spectrapor  3 tubing against 
0.5% acetic acid and lyophilized. Residual ampholytes were removed by two successive 
extractions with 0.25 ml of 10% trichloroacetic acid, in which the protein was precipitated 
by a  10-rain centrifugation at ~13,800 g, with a final precipitation in 0.2 ml of -10°C 
acetone. 
Amyloid protein AA was extracted from amyloidotic livers of C57BL/Ks mice injected 
with Cm~dida albiccms (14), from amyloidotic spleens of CBA/J mice subjected to 2-3 wk 
of daily casein  administration (15),  and  from mixed amyloidotic tissue  (liver,  spleen, 
kidney) of casein-treated C57BL/6J mice (the latter provided by Dr. Z. Ali-Khan, Depart- 
ment  of Microbiology and  Immunology,  McGill  University).  Samples  of tissue  were 
homogenized,  extracted,  and  centrifuged  (finally  in  6  M  urea/0.01  M  HCOONa/ 
HCOOH, pH 3.0) essentially as previously described (14). The centrifuged urea/formic 
acid extracts were lyophilized after dialysis in Spectrapor 3 tubing vs. 0.5% CH3COOH. 
Protein AA was isolated from the lyophilized products by Sephadex G-100  chromatog- 
raphy in the urea/formic acid buffer (14).  In another approach, crude protein AA was 
extracted from the washed and homogenized tissues by sonication and boiling in 7.5% 
sodium dodecyl sulfate (SDS); protein AA was purified by elution (16) following SDS/ 
urea polyacrylamide gel electrophoresis (PAGE) (16) of the crude extract. 
A~mlysis.  SDS/urea PAGE was performed as described elsewhere (13). 
N H2-terminal amino acid sequences were determined with a Beckman sequencer (Model 
890C) as described previously (17). 
Results and Discussion 
Fig.  1 shows SDS/urea  PAGE patterns of mouse HDL apoproteins (a  and b) 
and purified amyioid proteins (c-e).  By comparison with the apoprotein content 
of control  mouse  HDL  (a),  the  HDL  obtained  from  mice  20  b  following 
endotoxin administration  is  enriched  in  two polypeptides,  apoSAA1  (12.6  kd) 
and apoSAA2  (11.8  kd).  Lanes c and d  show purified apoSAA~  and apoSAAz, 
respectively, prepared by isoelectric focusing. Lane e shows chromatographically 
purified murine amyloid protein AA (8.6 kd). 
Fig.  2  shows  the  NH2-terminal  amino  acid  sequences  of purified  murine 
apoSAAb  apoSAA2,  and  amyloid  protein  AA  obtained  from  several  mouse 
strains.  Each purified apoSAA isotype was observed to be a  single polypeptide 
through  26  NH2-terminal  residues,  differing  from  the  other  isotype  in  two 
positions,  namely  residues  6  and  7.  Whereas  apoSAA~  contained  valine  and 
histidine, respectively, in these positions, the corresponding sequence in apoSAA9 
was isoleucine-glycine. This difference was a  consistent finding within the three 
mouse strains (BALB/c, C57BL/KsJ, and CBA/J) examined. A comparison with 
two previous reports (12,  18) reveals that our findings are consistent with those 
of Anders et al.  (12),  who found both  valine and isoleucine at position  6,  the HOFFMAN  ET  AL.  BRIEF  DEFINITIVE REPORT  643 
FIGURE  1.  SDS/urea  polyacrylamide  gel  electrophoretic  patterns  of (a)  normal  mouse 
(BALB/c) HDL apoproteins, (b) HDL apoproteins obtained 20 h following bacterial endotoxin 
administration,  (c) apoSAA] and (d) apoSAA~, purified by isoelectric focusing, and (e) murine 
(C57BL/6J) amyloid  protein  AA.  Molecular  weight  (MW) markers are ovalbumin  (43  kd), 
soybean trypsin  inhibitor (20 kd), cytochrome c (12.4 kd), and monkey amyloid protein AA 
(8.6 kd). 
Mouse 
Protein  Strain 
SAA  1  CBA/d 
SAA  1  BALB/c 
5AA  1  C57BL/ksJ 
SAA  z  CBA/d* 
S~  BALB/c 
SAA  2  C57BL/ksd 
AA  CBAIJ 
AA  CS7BL/ks** 
Nk  CS7BL/EJ 
Observed Sequence 
1  5  10  15  20  25  30  35 
GFFSFVHEAFQGAGDMWRAYTDMKEANWKNSDKYFHAR 
..........................  ?  -  -  ?  -  - 
............................ 
....  ?IG  ......  ?  ........... 
.....  IG  ................... 
.....  IG  ..............  ?  .... 
.....  IG  ...................  G--DG  ....... 
.....  IG  ...................  G- 
.....  IG  ..........  ?  ........  G--O 
*Mixture  of 40%  as  written  and  60)  starting  at  residue  6. 
**From  6rlksen  et al.  (14). 
FIGURE 2.  Amino-terminal  sequences ofapoSAA isotypes and tissue protein AA from various 
strains of mice. A hyphen indicates identity with apoSAAi (top line). A question mark indicates 
that  the  identification  was  not  accomplished.  Single  letter  code: alanine,  A;  arginine,  R; 
asparagine,  N; aspartic  acid,  D;  glutamine,  Q;  glutamic  acid,  E; glycine,  G;  histidine,  H; 
isoleucine, I; lysine, K; methionine,  M; phenylalanine,  F; serine, S; threonine, T; tryptophan, 
W; tyrosine,  Y; valine, V. 
presumptive result of analyzing a mixture of apoSAA1 and apoSAA2; at position 
7 they found only glycine. Anders et al. (12) also reported that ~35% of their 
sample, lacking the NH2-terminal pentapeptide, began at isoleucine, a phenom- 
enon that we also encountered in one of three samples of apoSAA2 (from CBA/ 
J  mice). In another study, Gorevic et al. (18) found a  mixture of glutamic acid 
and  valine at  position  6  in  sequences of apoSAA  from  several  mouse strains 
(including BALB/c), isoleucine with valine at this position in only one instance, 644  HOFFMAN ET  AL.  BRIEF  DEFINITIVE REPORT 
and glycine in position 7 in all cases; at other positions they found mixtures of 
amino acids not observed either by us or by Anders et al. (12).  The failure of 
previous  workers  to  detect  histidine  in  addition  to  glycine  at  position  7  (as 
expected from samples containing both apoSAAl  and apoSAA~) might be ex- 
plained  if,  in  the  earlier  studies,  only  the  organic-soluble  PTH-amino  acid 
derivatives were examined at this position, leaving the aqueous-soluble histidine- 
PTH  derivative  undetected.  The  unambiguous assignment of a  single amino 
acid sequence to each of the two apoSAA isotypes in the present study clearly 
identifies them as distinct polypeptides translated  from different genes rather 
than as posttranslationally modified forms of a single precursor. 
We  next  examined  the  amino  terminal  sequence  of protein  AA  found  in 
amyloid deposits to determine whether it corresponded to one or both serum 
apoSAA isotypes. The NH2-terminal segments of protein AA from several strains 
of mice were examined for isotype-specific sequences in positions 6 and 7. The 
sequences obtained for protein AA isolated from the mixed tissues (liver, spleen, 
and kidney) of CBA/J mice and C57BL/6J  mice, and the previously published 
sequence of liver protein AA from C57BL/Ks mice (14) are shown in Fig. 2. In 
all cases, amyloid protein AA showed NH2-terminal amino acid sequence identity 
with murine apoSAA2.  Sequences corresponding to apoSAAl,  i.e., containing 
the valine-histidine pair in positions 6 and 7, were not detected under conditions 
that would have identified 5%.  Furthermore, we observed differences between 
amyloid protein AA and apoSAAl at residues 27, 30, and 31 (as shown, Fig. 2), 
although a comparison with both serum isotypes was not possible in this region. 
In one experiment, protein AA was purified by elution from gel slices after 
SDS  PAGE  (16)  of proteins obtained  by extraction  of amyioidotic C57BL/6J 
tissues in 7.5% SDS, a method that solubilizes >90% of the tissue protein content 
(J. Hoffman, unpublished observations). Again, the protein AA obtained by this 
method  exclusively  contained  apoSAA2-type  sequences,  indicating  that  these 
observations do not result from an artifact of our preparative methods. 
Gorevic  et al.  (18)  originally  suggested the possibility  that  murine amyloid 
protein  AA  might  be  derived  from  only  one  of several  forms  of apoSAA 
polypeptides.  Our  present  findings  show,  first,  that  the  two  major  murine 
apoSAA isotypes are separate  gene products and second, that amyloid protein 
AA  could  be  derived  from  only  one  of of these,  namely  apoSAA2.  Several 
mechanisms could explain  these  observations.  Differences in  the structure  of 
murine apoSAA1 and apoSAA2 may play a  role  in the selective deposition of 
apoSAA2-derived protein AA during the pathogenesis of amyloidosis, or both 
proteins may be initially deposited but broken down at different rates,  leading 
to the selective retention of apoSAA2-derived protein AA. Alternatively, differ- 
ential gene expression during chronic inflammation could result in the prefer- 
ential synthesis of apoSAA2 during amyloidogenesis. We note that in addition to 
the two major isotypes sequenced here we observe trace bands upon isoelectric 
focusing that may correspond  to minor apoSAA isotypes (13),  consistent with 
the  recent  report  of an  mRNA-derived  plasmid  that  encodes  a  polypeptide 
having only 71% identity with the NH~-terminal region (residues 8-28) ofmurine 
amyloid protein AA (19). 
We recently reported the complete 104-amino acid sequence of one fraction HOFFMAN  ET  AL.  BRIEF  DEFINITIVE  REPORT  645 
of human  apoSAA (13) containing  two distinct proteins that  differ from each 
other only at positions  52 and  57.  The  first  20 residues of both are identical 
with those reported  for human  protein  AA from several laboratories (20-22), 
but amino acids reported for the tissue amyloid proteins at residues 23, 53, 60, 
66, 69, 71, and 75 are not in accord with our identifications in the two apoSAA 
subspecies found (13). Thus, there appear to be several human allotypes and/or 
gene  loci  coding  for apoSAA  and  protein  AA.  By analogy  with  our  findings 
using the animal  model,  the intriguing  possibility is suggested that  in  humans 
protein AA is derived from a subset of the total complement of apoSAA isotypes. 
Summary 
Amyloid protein  AA  is  the  presumptive  fragment  of an  acute phase  serum 
apolipoprotein,  apoSAA.  Two major  murine  apoSAA  isotypes (apoSAAl  and 
apoSAA2)  have  been  identified.  The  NH~-terminal  amino  acid  sequences  of 
purified murine apoSAA~ and apoSAA2 have been examined and compared with 
that  of murine  amyloid  protein  AA.  Our  results  indicate  that  apoSAAl  and 
apoSAA2 are  separate  gene  products  and  that  amyloid protein  AA has  NH2- 
terminal  amino acid sequence identity with only one of these isotypes, namely 
apoSAA2. 
We thank Virginia Wejak for her help in preparing the manuscript. 
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